Physician

Mark Jung-Ching Shen, M.D.

According to 2025 Medicare claims, Mark Shen, M.D. (NPI: 1346539467) practices internal medicine in the Davenport-Moline-Rock Island, IA-IL market, with the plurality of this provider's patient population coming from Rock Island, IL. This provider's primary affiliated billing organization is CARDIOVASCULAR MEDICINE PLLC (NPI: 1982632907; TIN: 421085919) and primary practice location at 61265-7127. Shen is affiliated with the IRCCO (ACO ID: A2619), Northwestern Medicine Physician Network ACO (ACO ID: A2620), Genesis Accountable Care Organization, LLC. (ACO ID: A4799), and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Shen's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 2,383 traditional Medicare patients, billed 16,620 HCPCS/CPT codes, and received $645,859 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 8,795 prescription claims across 1,348 beneficiaries totaling $2,294,175 in drug costs, led by Eliquis (Apixaban). DME data shows 11 claims. Open Payments data shows 98 records totaling $13,638. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $2,873 to $645,859. Similarly, Part D prescription costs have risen steadily, from $3,252 to $2,294,175. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	30	30	$2,873
2019	522	1,479	$113,888
2020	1,003	5,121	$452,120
2021	1,115	6,188	$537,202
2022	1,166	5,155	$426,684
2023	1,899	12,292	$508,147
2024	2,383	16,620	$645,859

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	36	90	$3,252
2016	54	148	$11,265
2017	56	263	$31,709
2018	28	65	$12,613
2019	100	193	$34,438
2020	278	1,256	$282,549
2021	334	1,590	$463,323
2022	322	1,646	$551,821
2023	1,151	4,910	$1,216,553
2024	1,348	8,795	$2,294,175

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	25	25	$2,063
2021	39	39	$3,095
2022	14	14	$1,210
2023	N/R	12	$29,538
2024	N/R	11	$26,822

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	846	1,068	$89
93294	Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days	362	896	$21
93296	Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days	516	1,279	$15
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	1,069	1,630	$10
93010	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	590	842	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	1,306	83,257	$1,597,337
Entresto	Sacubitril/Valsartan	162	9,355	$204,488
Xarelto	Rivaroxaban	150	10,406	$190,360
Multaq	Dronedarone Hcl	55	3,270	$81,728
Jardiance	Empagliflozin	42	1,935	$37,967

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
K0606	Automatic external defibrillator, with integrated electrocardiogram analysis, garment type	Y	N/R	11	$26,822

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	93	$4,930	Medtronic, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	5	$8,708	CVRx, Inc.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Mark Jung-Ching Shen, M.D.?

Tedicare shows public-source Medicare data for Mark Jung-Ching Shen, M.D. (NPI 1346539467), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Mark Jung-Ching Shen, M.D. have ACO affiliation data?

Mark Jung-Ching Shen, M.D. is shown with ACO affiliation data for IRCCO (MSSP, ACO ID A2619), Northwestern Medicine Physician Network ACO (MSSP, ACO ID A2620), Genesis Accountable Care Organization, LLC. (MSSP, ACO ID A4799), and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Mark Jung-Ching Shen, M.D.?

Mark Jung-Ching Shen, M.D. is linked to CARDIOVASCULAR MEDICINE PLLC (billing NPI 1982632907) in the available physician profile data.

Does Mark Jung-Ching Shen, M.D. have Open Payments data?

Mark Jung-Ching Shen, M.D. has 98 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.